lpr/lpr first (around 5 weeks) is characterized by infiltration of animals were resistant to diabetogenic T cells and to the islets of Langerhans with lymphoid and myeloid cells spontaneous diabetes. Thus, induction of Fas exprescalled insulitis, and the second (around 12 weeks) is sion on ␤ cells and their subsequent destruction conmarked by massive destruction of insulin-producing ␤ cells, leading to diabetes. T cells have been shown to stitutes the main pathogenic mechanism in autoimplay a crucial role in the disease (for review, see Tisch mune diabetes.
and McDevitt, 1996) . In theory, expression of FasL by ␤ cells might lead to the destruction of activated autoreIntroduction active Fas-expressing T cells and thus protect the islets. Such islets could be used for transplantation into diaAdaptive immunity provides protection from the multibetic recipients in order to normalize insulin productude of exogenous infectious agents, which are recogtion. A recent study involving transplantation of FasLnized by clonal receptors expressed by T and B lymphoexpressing myoblasts together with pancreatic islets cytes. The diversity of clonal receptors is based on (Lau et al., 1996) has supported the feasibility of this random combinations of receptor gene segments proapproach. duced during T and B cell maturation. For that reason, To our surprise, some animals expressing FasL in clones of lymphocytes with receptors recognizing self pancreatic islets showed higher rates of spontaneous antigens are constantly produced and must be elimidiabetes, and all transgenic animals were more sensitive nated or suppressed by regulatory mechanisms. A subto diabetogenic T cells than their nontransgenic litstantial breakthrough in understanding the regulatermates. Further studies revealed that ␤ cells are intory mechanisms in autoimmunity came from studies of duced to express Fas by T cells. This suggested that mice with lpr (lymphoproliferation) and gld (generalized FasL transgenic ␤ cells were committing suicide (or fratlymphoproliferative disease) mutations. Both mouse ricide) upon induction of Fas. More importantly, we strains demonstrate expansion of lymphocytes with an found that the ability to upregulate Fas is acquired by unusual surface phenotype and a variety of autoimmune ␤ cells during the natural course of diabetes in NOD reactions. lpr and gld were found to be complementary mice, indicating that Fas-mediated apoptosis of ␤ cells mutations of a receptor and its ligand (Allen et al., 1990;  may be the major mechanism for decrease in insulin Watanabe-Fukunaga et al., 1992a; Lynch et al., 1994;  production and establishment of diabetes. Takahashi et al., 1994) . The receptor appeared to be Fas protein (CD95), a member of the TNF-receptor family. It
Results and Discussion RIP-FasL Transgenic Animals § To whom correspondence should be addressed.
We prepared a construct ( Figure 1A ) in which FasL exThese authors made equal contributions to this paper. # These authors made equal contributions.
pression is driven by the rat insulin promoter-1 (RIP), limiting gene expression to ␤ cells (Hanahan, 1985) . We
Diabetes in RIP-FasL Transgenic Mice
To determine if transgene expression would alter the chose to inject the DNA into oocytes of NOD mice directly, rather than breed conventional transgenic mice natural course of diabetes, the RIP-FasL mice together with negative littermates were observed for a 25-week back to the NOD background in order to eliminate any undesired contribution of non-NOD genes to the genetic period, and the incidence of diabetes was followed. Surprisingly, the incidence of diabetes in different strains background of these mice. Several founders of NOD-RIP-FasL mice were obtained. Expression of functional varied dramatically (Figure 2a ). While normal NOD mice start to develop diabetes around 12 weeks of age, in FasL protein could be demonstrated in a thymocyte killing assay, in which overnight coincubation of B6 thysome transgenic lines disease was accelerated. Thus, one founder, NOD-RIP-FasL-25, became diabetic at the mocytes with ␤ cells isolated from transgenic animals but not from nontransgenic littermates led to apoptosis age of six weeks and therefore did not produce progeny. The majority (but not all) of the mice of another strain, of thymocytes (data not shown). FasL expression was also determined by reverse transcription-polymerase NOD-RIP-FasL-24, turned diabetic starting from week 10. NOD-RIP-FasL-32 showed no difference in incichain reaction (RT-PCR) ( Figure 1B) . None of the animals were diabetic as determined by blood glucose level at dence of diabetes compared with nontransgenic NOD littermates, while NOD-RIP-FasL-31 were relatively rethe time of sacrifice. Therefore, insulin was used to standardize the amount of ␤ cell-specific cDNA for comparisistant to diabetes, with only a few animals showing glucosuria at 25 weeks. son between samples. These reactions produced products of 620 bp and 357 bp for Fasl transgene and insulin,
The histological examination of pancreatic tissues from these mice revealed that in diabetic NOD-RIPrespectively ( Figure 1B , left panel). To ensure that the amount of PCR product generated from actual cDNA FasL-25 and NOD-RIP-FasL-24 mice, islets were significantly damaged, with very little insulin remaining (Figcould be quantitatively measured, we performed simultaneous titration of templates in 10 Ϫ1 steps ( Figure 1B , ures 2b and 2c). In contrast, NOD-RIP-FasL-31 islets (25 weeks old) were well preserved, with infiltration ocright panel). Transgenic strain NOD-RIP-FasL-31 was found to express considerably more Fasl mRNA than curing in some islets mostly in the form of periinsulitis (Figures 2d-2f ). Age-matched nontransgenic NOD mice NOD-RIP-FasL-24 and NOD-RIP-FasL-32. 
␤ Cells Can Express Fas
The demonstration that Fas can in fact be expressed by ␤ cells came from the following experiments. Cytotoxic CD8 ϩ islet-specific T cell clones have been shown previously to cause severe damage to ␤ cells, leading to hyperglycemia and rapid death following their adoptive Wong et al., 1996) . When such T cells measurements of urine glucose. The number of observed animals (Wong et al., 1996) were injected into irradiated NOD is shown in parentheses.
and NOD-RIP-FasL-32 transgenic mice, substantial ac- were severely damaged (data not shown). Furthermore, and CD8 ϩ (f) T cells, while the nontransgenic 25-week-old littermate the same accelerated disease was obtained with all has severe infiltration with both CD4 ϩ (g) and CD8 ϩ (h) cells.
NOD-RIP-FasL transgenic strains tested (Table 1) . The diabetes-inducing potential of the CD8 ϩ T cells was overwhelming, so that even otherwise protected NODdemonstrated massive infiltration of the islets with CD4 RIP-FasL-31 mice showed accelerated diabetes. These and CD8 T cells (Figures 2g and 2h) . The islet destruction results suggested that the underlying mechanism for in transgenic mice with accelerated diabetes ruled out diabetes induction must be uniform for all RIP-FasL the possibility of nonspecific inhibition of insulin productransgenic strains. Presumably, the CD8 ϩ T cells protion, as has been reported for another RIP-driven duced a factor(s) inducing Fas expression by the ␤ cells. transgene (Allison et al., 1991) .
Engagement of FasL expressed by transgenic ␤ cells Although intact normal islets do not express Fas (an resulted in ␤ cell killing. observation based on immunohistochemical examination of the NOD islets as well as FACS staining of isolated FasL to destroy all incoming T cells but are able to ) were injected IV into irradiated NOD animals of different ages. * Diabetic/total injected ratio.
correlation between the ability to express Fas and the natural course of diabetes in NOD mice. IDDM in NOD mice is obviously a chronic illness marked by stepwise development with characteristic checkpoints (André et al., 1996) . At about 12 weeks of age, the insulitis turns following experiments. First, NOD mice of different ages were injected with the CD8 ϩ T cell clone TGNF-H3 (Table  Assuming that possibilities, we conducted histological examination of mice were resistant to the diabetogenic effects of the the pancreata from young and older animals. In such a transferred T cells. None of 5 NOD lpr/lpr mice in the first kinetic experiment, in which irradiated NOD mice of 4-5 experiment were diabetic 20 days postinjection, at weeks and 12ϩ weeks of age were injected with equal which time point they were sacrificed, whereas NOD ϩ/ϩ numbers of the CD8 ϩ T cells and sacrificed at different littermates became diabetic within 6 days ( Figure 4) . In time points, it was demonstrated that CD8 ϩ T cells could the second experiment, NOD lpr/lpr recipients with normal be detected in both young and older animals alike, sugblood glucose levels were sacrificed 3 days after their gesting that homing was similar in both age groups Fas-sufficient littermates became diabetic. The results ( Figure 6 ). Furthermore, in the 12-week-old group, Fas of histological examination of their pancreata are shown on islet cells could be detected by staining with the in Figure 5 . The lpr mutation did not affect homing of monoclonal antibody JO2 on day 2 after transfer of the the TGNF-H3 cells into the pancreas. V␤6 ϩ -infiltrating T cells ( Figures 6A[e] and 6B [d] ), while in younger anicells were found in the islets of both NOD and NOD lpr/lpr mals it was undetectable even on day 4 ( Figure 6A[a-c] ). mice (Figure 5d ), but ␤ cells in the NOD mice were more Thus, the ability to rapidly upregulate Fas is acquired severely damaged than in NOD lpr/lpr (Figures 5g-5i) . Fas with age. It should be stressed, however, that young induction was obvious in the NOD islet cells ( Figure  RIP -FasL transgenic NOD mice showed accelerated dia5h). In contrast, in NOD lpr/lpr animals insulin production betes following CD8 ϩ T cell transfer, suggesting that remained high (Figures 5c and 5f ), and Fas staining was young NOD mice can be induced to express Fas on associated only with Fas ϩ infiltrating CD8 ϩ T cells (Figtheir ␤ cells to levels that make them sensitive to FasL ures 5b and 5e). Fas expression by the adoptively transexpressed by ␤ cells, but which are too low to be deferred CD8 ϩ T cells was confirmed by FACS analysis tected by immunohistochemical staining. Similarly, up- (Figure 5a ). Thus, the pathogenic effect of the CD8 ϩ T regulation of Fas by an insulinoma cell line ␤-TC1 in cells is primarily via the Fas-mediated pathway. It should vitro was documented by RT-PCR, while the levels of be noted, however, that the transferred T cells are able Fas on cell surface remained undetectable by staining to produce perforin and TNF␣ (Wong et al., 1996) , as with monoclonal antibodies (Yamada et al., 1996) . well as FasL (data not shown). This might explain the Finally, the importance of Fas in the natural course of fact that some destruction of the NOD lpr/lpr islets was diabetes was confirmed by determination of the inciobserved (Figure 5c ). Presumably, cytotoxic mechadence of spontaneous diabetes in the NOD lpr/lpr animals nisms other than signaling through Fas may contribute compared to NOD ϩ/ϩ littermates. Based on the data of to ␤ cell damage.
T cell transfer experiments, one would anticipate that Fas-negative NOD lpr/lpr mice would be resistant to sponThe Role of Fas in the Natural Course of Diabetes taneous diabetes, given that Fas-mediated apoptosis is Since Fas-mediated destruction of ␤ cells has been demonstrated by the above experiments, we sought a a major mechanism of ␤ cell destruction. In fact, none of the NOD lpr/lpr mice had elevated glucose levels at the experiments (Wong et al., 1996) . The NIT-1 insulinoma cell line (Hamaguchi et al., 1991) became sensitive to end of a 25-week observation period, while Fas-sufficient littermates showed over 75% incidence of diabetes lysis by FasL-expressing fibroblasts after treatment with interferon-␥ (data not shown), which has also been re- (Figure 7) .
Taken together, our data suggest that Fas-mediated ported to induce Fas on other cell types (Yonehara et al., 1989; Watanabe-Fukunaga et al., 1992b ; Takahashi destruction of ␤ cells is indeed a part of the natural diabetogenic process in NOD mice. As defined by et al., 1995) . Also, IL-1 has been implicated in stimulation of Fas expression on human (Stassi et al., 1996) and Mathis, Benoist, and their colleagues (André et al., 1996) , development of IDDM in NOD mice is characterized by mouse (Yamada et al., 1996) ␤ cells in vitro. It is, of course, possible that a combination of cytokines may two checkpoints. The first is the onset of insulitis (around 5 weeks) with no significant damage to the islets; the be more potent in Fas induction than individual factors. TGF␤ has been identified as an active factor produced second is diabetes (around 12 weeks) with islet destruction and hyperglycemia. The acquisition of the ability to by T cell clones that protect from diabetes (Han et al., 1996) . Whether this cytokine is able to inhibit Fas expresupregulate Fas to detectable levels correlates well with the time of this second checkpoint. Thus, the severity sion or activity, or whether it neutralizes Fas induction by other cytokines, remains to be studied. At least 15 of islet destruction may be attributed to the induction of Fas on the ␤ cells. Fas-dependent cytotoxicity may genes have been reported to be responsible for susceptibility of NOD mice to autoimmune diabetes (Wicker et be elicited both by CD8 T cells (Rouvier et al., 1993) and by Th1-type CD4 T cells (Ramsdell et al., 1994 ). Both al., 1995 Tisch and McDevitt, 1996; Vyse and Todd, 1996) . Whether any of them influence Fas expression, CD4 and CD8 cells are involved in development of diabetes (summarized in Tisch and McDevitt, 1996, and André and what exactly determines the timing of Fas induction around 12 weeks of age, needs to be determined. Preet al., 1996) . Recently published data suggest that the shift of the autoimmune response in NOD mice toward liminary experiments (data not shown) demonstrated that NOD-RIP-FasL transgenic mice crossed to mice of Th1 correlates with severe pathology (Lenschow et al., 1996) . Our preliminary experiments suggest that Th1 different genetic backgrounds remain more sensitive to CD8 ϩ cells than their nontransgenic littermates, arguing cytokines, specifically interferon-␥, may be involved in the stimulation of Fas expression by ␤ cells. This cytothat Fas induction does not require the entire NOD background. It is also noteworthy that Fas function in NOD kine is produced by the CD8 cells used in our in vivo mice is normal, as thymocytes of NOD mice were killed benign infiltration to detrimental destruction of the islets. Fas-mediated apoptosis appears to be the predominant by FasL-expressing fibroblasts (gift of I. N. Crispe, Yale University) to the same extent as B6 thymocytes mechanism in T cell-mediated damage to insulin-producing ␤ cells. It is important to determine whether in-(73.7% Ϯ 4.3% and 69.9% Ϯ 4.8%, respectively).
The role for Fas-FasL interaction in autoimmunity duction of Fas and Fas-mediated apoptosis of target cells is involved in human IDDM as well as other T cell-(based on the inability to control autoreactive T cells owing to abnormalities in these two molecules) has been mediated autoimmune disorders. Our findings also put certain constraints on the use appreciated for lymphoproliferative disorders in humans (Fisher et al., 1995; Rieux-Laucat et al., 1995) and aniof FasL-expressing tissues for transplantation, the idea that led to the present study. It has been reported that mals. Our studies have revealed a second major mechanism of autoimmunity involving Fas, i.e., induction of FasL expression by grafted fibroblasts may stimulate their destruction (Yagita et al., 1996) , but whether or not Fas expression on target cells and their subsequent destruction. Expression of Fas by pancreatic ␤ cells has the destruction was caused by induction of Fas on the graft has not been tested. Generation of Fas-negative been shown to have a major influence on the susceptibility of NOD mice to diabetes and to be associated with FasL-positive tissues may constitute a better approach for construction of indestructible grafts. a critical transformation in the course of diabetes from
Experimental Procedures Transgene Construction and Evaluation of Transgene Expression
The RIP-Fasl DNA constuct was prepared by subcloning Fasl cDNA (gift of Dr. I. N. Crispe, Yale University) into pSR␣(N1) vector (Hughes and Crispe, 1995) . The FasL insert was excised by XbaI and SacI enzymes, gel purified, and the ends were blunted by T4 DNA polymerase (GIBCO-BRL, Grand Island, NY) treatment. Human B7 cDNA insert was removed from the RIP-E␣-B7 construct (Lo et al., 1988; Guerder et al., 1994) by XhoI enzyme digestion, the vector was gel purified, and the ends were blunted by Klenow fragment DNA polymerase (GIBCO-BRL) treatment, dephosphorylated, and the FasL insert was subcloned into this vector. The orientation of the insert was verified by restriction analysis, and the accuracy of sequences at the 5Ј and 3Ј ends of FasL coding region was verified Figure 7 . Fas-Deficient NOD lpr/lpr Animals Are Resistant to Spontaneby sequencing. DNA was prepared for injection by purification of ous Diabetes the 3.75 kb HinPI fragment. Oocyte microinjections were performed by Yale DERC Transgenic Facility. Primers used for Tg screening Incidence of diabetes in NOD and NOD lpr/lpr mice. Animals were followed for 25 weeks with weekly measurements of urine glucose.
were forward RIP 5-ЈCAAGACTCCAGGGATTTGAGGGA-3Ј and reverse FasL 5Ј-CTTTTAAAGCTTATACAAGCCGAAAAAGGT-3Ј. Twelve The number of observed animals is shown in parentheses. mice on NOD background tested positive for transgene by PCR.
